SCS logo

Stem Cells Spin S.A. Stock Price

WSE:SCS Community·zł16.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SCS Share Price Performance

zł0.41
0.19 (88.89%)
zł0.41
0.19 (88.89%)
Price zł0.41

SCS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk and good value.

5 Risks
1 Reward

Stem Cells Spin S.A. Key Details

zł115.7k

Revenue

zł10.3k

Cost of Revenue

zł105.4k

Gross Profit

zł616.3k

Other Expenses

-zł510.9k

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.012
91.06%
-441.45%
2.7%
View Full Analysis

About SCS

Founded
2009
Employees
1
CEO
Adam Symber
WebsiteView website
stemcellsspin.com.pl

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wroclaw, Poland. Stem Cells Spin S.A. is a subsidiary of Medcervin Sp. z o.o.

Recent SCS News & Updates

Recent updates

No updates